Loading...
In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistance
Overexpression of P-glycoprotein (P-gp) is a potential cause of multidrug resistance (MDR) in tumours. We have previously reported that XR9051 (N-(4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydro-2-isoquinolyl)ethyl)phenyl)-3-((3Z,6Z)-6-benzylidene-1-methyl-2,5-dioxo-3-piperazinylidene)methylbenzamide) is a p...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
1999
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2362811/ https://ncbi.nlm.nih.gov/pubmed/10206276 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690267 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|